SMARCAL1 Resolves Replication Stress at ALT Telomeres

Cell Reports
Kelli E CoxRachel Litman Flynn

Abstract

Cancer cells overcome replicative senescence by exploiting mechanisms of telomere elongation, a process often accomplished by reactivation of the enzyme telomerase. However, a subset of cancer cells lack telomerase activity and rely on the alternative lengthening of telomeres (ALT) pathway, a recombination-based mechanism of telomere elongation. Although the mechanisms regulating ALT are not fully defined, chronic replication stress at telomeres might prime these fragile regions for recombination. Here, we demonstrate that the replication stress response protein SMARCAL1 is a critical regulator of ALT activity. SMARCAL1 associates with ALT telomeres to resolve replication stress and ensure telomere stability. In the absence of SMARCAL1, persistently stalled replication forks at ALT telomeres deteriorate into DNA double-strand breaks promoting the formation of chromosome fusions. Our studies not only define a role for SMARCAL1 in ALT telomere maintenance, but also demonstrate that resolution of replication stress is a crucial step in the ALT mechanism.

References

Feb 18, 2004·Molecular and Cellular Biology·Vitaly M VassinJames A Borowiec
Apr 3, 2004·Cancer Research·J Arturo Londoño-VallejoRoger R Reddel
Oct 21, 2006·The Journal of Biological Chemistry·Nicole FouchéJack D Griffith
Oct 16, 2007·Nature Structural & Molecular Biology·Katsuhiro HanadaRoland Kanaar
Aug 6, 2008·Annual Review of Genetics·Wilhelm Palm, Titia de Lange
Nov 1, 2008·Science·Timur Yusufzai, James T Kadonaga
Nov 19, 2008·Molecular and Cellular Biology·Akira Nabetani, Fuyuki Ishikawa
Feb 7, 2009·The EMBO Journal·Anaïs PouletMarie-Josèphe Giraud-Panis
Apr 14, 2009·Nature Cell Biology·Sicong ZengQin Yang
Sep 1, 2009·Proceedings of the National Academy of Sciences of the United States of America·Irena DraskovicArturo Londoño-Vallejo
Oct 2, 2009·Genes & Development·Carol E BansbachDavid Cortez
Oct 2, 2009·Genes & Development·Jingsong YuanJunjie Chen
Jul 2, 2011·Science·Christopher M HeaphyAlan K Meeker
May 18, 2012·Molecular Biology of the Cell·Evert-Jan UringaPeter M Lansdorp
Aug 28, 2012·Nucleic Acids Research·Loretta M S LauRoger R Reddel
Dec 12, 2012·The Journal of Cell Biology·Dimitri ConomosHilda A Pickett
Jan 15, 2014·Nature Structural & Molecular Biology·Roderick J O'SullivanJan Karlseder
Jan 27, 2015·Molecular Cell·Grzegorz SarekSimon J Boulton
Nov 19, 2015·Proceedings of the National Academy of Sciences of the United States of America·Lisa A PooleDavid Cortez

❮ Previous
Next ❯

Citations

Jul 5, 2016·Frontiers in Genetics·Shane M Harding, Roger A Greenberg
Jun 30, 2016·Nucleus·Lisa A Poole, David Cortez
Nov 29, 2016·Critical Reviews in Biochemistry and Molecular Biology·Manasi S Apte, Julia Promisel Cooper
Feb 6, 2017·FEBS Letters·Benura Azeroglu, David R F Leach
Jun 9, 2017·International Journal of Molecular Sciences·Sanket Awate, Robert M Brosh
Jul 14, 2017·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Alexander J NeilSergei M Mirkin
Oct 5, 2018·Critical Reviews in Biochemistry and Molecular Biology·Jean-Hugues Guervilly, Pierre Henri Gaillard
May 30, 2019·Nature Communications·Robert LuHilda A Pickett
Jan 25, 2020·Journal of Cell Science·Emily FengXu-Dong Zhu
Feb 6, 2020·Genes·Aurore Sommer, Nicola J Royle
Apr 28, 2020·EMBO Reports·Emily Mason-OsannRachel Litman Flynn
Sep 15, 2018·Oncotarget·Emily Mason-OsannRachel Litman Flynn
Nov 4, 2016·Nature·Robert L DilleyRoger A Greenberg
Dec 19, 2017·Chromosoma·Mathieu Tardat, Jérôme Déjardin
Jul 28, 2020·Genes·Isaac Armendáriz-CastilloCésar Paz-Y-Miño
May 29, 2018·Nature Communications·Bill H DiplasHai Yan
Sep 26, 2019·Frontiers in Molecular Biosciences·Beatriz Domingues-SilvaClaus M Azzalin
Sep 29, 2017·Critical Reviews in Biochemistry and Molecular Biology·Lisa A Poole, David Cortez
Feb 11, 2020·Frontiers in Oncology·Thomas KentDavid Clynes
Jan 6, 2019·Cancer Research·Matthew V PuccettiChristine M Eischen
Feb 18, 2021·The EMBO Journal·Maya RaghunandanAnabelle Decottignies
Jun 18, 2017·DNA Repair·Natalia LugliThanos D Halazonetis
Nov 3, 2020·DNA Repair·Srijita DharRobert M Brosh
Dec 10, 2020·Seminars in Cell & Developmental Biology·Jennifer J LeeHyunsook Lee
Jun 10, 2021·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jacqueline A Brosnan-CashmanChristopher M Heaphy
Jun 30, 2021·Trends in Cell Biology·Noa LammAnthony J Cesare
Aug 14, 2021·Trends in Cell Biology·Esther A Epum, James E Haber
May 26, 2016·Genes & Development·Priyanka Verma, Roger A Greenberg

❮ Previous
Next ❯

Methods Mentioned

BETA
immunoprecipitation
transfections
transfection
dot blot

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.